Pfizerâs Phase 2 Study Demonstrates Safety, Tolerability and Immunogenicity of TRUMENBAÂ® When Coadministered with Meningococcal A, C, Y and W-135 Polysaccharide Conjugate (MCV4) and Tetanus, Diphtheria and Pertussis (Tdap